Connect with us

Business

Mcap Of 8 Of India’s Top-10 Most Valued Companies Jumps Rs 1.72 Lakh Crore

Published

on

Mcap Of 8 Of India’s Top-10 Most Valued Companies Jumps Rs 1.72 Lakh Crore


Last Updated:

From the top-10 pack, Reliance Industries, TCS, Bharti Airtel, ICICI Bank, Infosys, Hindustan Unilever Ltd, Life Insurance Corporation, and Bajaj Finance were the gainers.

font
Last week, the BSE benchmark jumped 709.19 points or 0.87 per cent.

Last week, the BSE benchmark jumped 709.19 points or 0.87 per cent.

The combined market valuation of eight of the top-10 most valued firms jumped Rs 1,72,148.89 crore last week, with Reliance Industries leading the pack with the maximum gain, in line with a bullish trend in domestic equities. Last week, the BSE benchmark jumped 709.19 points or 0.87 per cent.

From the top-10 pack, Reliance Industries, Tata Consultancy Services (TCS), Bharti Airtel, ICICI Bank, Infosys, Hindustan Unilever Ltd, Life Insurance Corporation of India (LIC) and Bajaj Finance were the gainers.

However, HDFC Bank and State Bank of India faced erosion in their valuation.

Reliance Industries added Rs 48,107.94 crore, taking its market valuation to Rs 19,07,131.37 crore.

The market capitalisation (mcap) of Hindustan Unilever jumped Rs 34,280.54 crore to Rs 6,17,672.30 crore.

Bharti Airtel’s valuation surged Rs 33,899.02 crore to Rs 11,02,159.94 crore, and that of Bajaj Finance zoomed Rs 20,413.95 crore to Rs 5,55,961.39 crore.

The mcap of Infosys edged higher by Rs 16,693.93 crore to Rs 6,18,004.12 crore, and that of TCS climbed Rs 11,487.42 crore to Rs 11,04,837.29 crore.

ICICI Bank added Rs 6,443.84 crore to its market valuation, which stood at Rs 10,25,426.19 crore.

The market valuation of LIC went up by Rs 822.25 crore to Rs 5,62,703.42 crore.

However, the mcap of HDFC Bank eroded by Rs 20,040.7 crore to Rs 15,08,346.39 crore.

The market valuation of State Bank of India declined by Rs 9,784.46 crore to Rs 7,53,310.70 crore.

Reliance Industries retained the title of the most valued firm, followed by HDFC Bank, TCS, Bharti Airtel, ICICI Bank, State Bank of India, Infosys, Hindustan Unilever, LIC and Bajaj Finance.

Stock Market Last Week: Technical View

Dhupesh Dhameja, research analyst (derivatives) of SAMCO Securities, said, “The Nifty index wrapped up the week on a turbulent note, forming a shooting star candlestick pattern on the weekly chart. On Friday, the index not only erased the gains of the previous four sessions but also printed an evening star, like formation, reinforcing signs of fatigue. Crucially, Nifty slipped below its psychological mark and created a classic bull trap scenario. The index declined sharply by 213.65 points, closing at 24,870.10, a move that underscores caution among market participants.”

Currently, the index hovers near its critical support zone of 24,800, a confluence of the 50-day and 20-day exponential moving averages (DEMA) along with gap support. With the broader trend turning sideways-to-weak, any attempt to rise is likely to encounter stiff resistance. The index has carved out a key swing high at 25,150, and unless it decisively reclaims this level, selling pressure at higher zones will persist, he said.

“Price action suggests a cautious undertone, with immediate resistance shifting lower to the 25,000-25,100 band. As long as the Nifty remains range-bound between 24,800 and 25,150, choppy to muted sessions are likely. A breakout beyond these zones, however, may set the stage for directional momentum. Meanwhile, the daily RSI continues to hover just above 50, reflecting a persistent sideways bias,” Dhameja added.

(With Inputs From PTI)

Disclaimer:Network18 and TV18 – the companies that operate news18.com – are controlled by Independent Media Trust, of which Reliance Industries is the sole beneficiary.

authorimg

Business Desk

A team of writers and reporters decodes vast terms of personal finance and making money matters simpler for you. From latest initial public offerings (IPOs) in the market to best investment options, we cover al…Read More

A team of writers and reporters decodes vast terms of personal finance and making money matters simpler for you. From latest initial public offerings (IPOs) in the market to best investment options, we cover al… Read More

News business » markets Mcap Of 8 Of India’s Top-10 Most Valued Companies Jumps Rs 1.72 Lakh Crore
Disclaimer: Comments reflect users’ views, not News18’s. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Read More



Source link

Business

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

Published

on

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease


Thomas Fuller | SOPA Images | Lightrocket | Getty Images

UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.

The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.

“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”

The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.

UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.

The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”

UniQure didn’t immediately comment.

The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.



Source link

Continue Reading

Business

US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India

Published

on

US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India


The average long-term US mortgage rate edged higher this week, ending a three-week decline as bond yields rose amid oil-price pressures linked to the war with Iran.The benchmark 30-year fixed mortgage rate increased to 6% from 5.98% last week, mortgage buyer Freddie Mac said on Thursday. A year ago, the average rate stood at 6.63%, AP reported.The modest uptick breaks a three-week slide in borrowing costs, with mortgage rates having hovered close to the 6% mark for most of this year. Last week’s average had marked the first time the rate dipped below 6% since September 2022, reaching its lowest level in nearly three and a half years.Mortgage rates are influenced by several factors, including the Federal Reserve’s interest-rate policy, investor expectations about inflation and economic growth, and movements in the bond market.They typically track the direction of the 10-year US Treasury yield, which lenders use as a benchmark for pricing home loans.The 10-year Treasury yield rose to 4.14% at midday Thursday, up from around 4% a week earlier.Treasury yields have moved higher in recent days as rising oil prices added fresh inflation concerns, potentially complicating the Federal Reserve’s plans to cut interest rates.



Source link

Continue Reading

Business

PSX reclaims 160k level with 5,433-point jump | The Express Tribune

Published

on

PSX reclaims 160k level with 5,433-point jump | The Express Tribune


Foreign funds would divert their liquidity into buying Pakistan’s stocks. This would merely increases prices of shares and be profitable for those who already hold stocks. PHOTO: FILE


KARACHI:

The Pakistan Stock Exchange on Thursday staged a powerful rebound, when the benchmark KSE-100 index surged by over 5,400 points, reclaiming the 160,000 level in a decisive rally driven by strong institutional buying and renewed investor confidence.

The session marked a sharp recovery from recent volatility as bulls took control from the opening bell. Index-heavy stocks like Hubco (+7.15%), OGDC (+8.24%) and others led the charge, contributing significantly to the gains, while trading volumes rose to 724 million shares valuing at Rs35 billion. K-Electric dominated the volumes with over 115 million shares traded.

At the close of trading, the KSE-100 index posted a strong gain of 5,433.46 points, or 3.49%, and settled at 161,210.68.

According to Arif Habib Limited (AHL), the stock market staged a strong rebound as the benchmark index pushed higher from its 200-day moving average, gaining 3.49% to reclaim the 160,000 level. Market participation remained broadly positive, with 85 shares advancing while 14 declined among key index movers.

The major contributors included Hubco, which rose 7.15%, OGDC, higher by 8.24%, and Fauji Fertiliser, which despite declining 2.93% remained among the notable stocks influencing index movements. On the downside, Abbott Laboratories fell 3.5%, Highnoon Laboratories declined 2.42% and Fatima Fertiliser slipped 0.82%, emerging as the biggest drags on the index.

Meanwhile, geopolitical and macroeconomic developments also remained in focus. Pakistan’s top military leader stated that the country was willing to halt operations against Afghanistan if the Taliban government stopped supporting terror groups operating from its territory. On the economic front, Saudi authorities assured Pakistan of secure energy supplies through the Port of Yanbu on the Red Sea, helping support the country’s energy requirements, it said.

Additionally, Pakistan was preparing to introduce several measures, including weekly petroleum price revisions, compensation to oil companies for higher insurance costs and import premiums, and fuel conservation initiatives. Finance Minister Muhammad Aurangzeb also assured a parliamentary panel that Pakistan had adequate petroleum reserves, including 28 days of petrol and diesel supply.

Despite the strong rebound during the session, the market remained down about 4% week-on-week while heading into the final trading day and continued to trade within the large gap created by Monday’s sharp decline, AHL said.

“Bulls stormed back with authority in Thursday’s trading session, firmly planting their feet from the outset,” Topline Securities stated in its review. Strong institutional buying turned the tide after the market’s recent overreaction to regional issues, as confidence swiftly replaced caution.

Momentum gathered strength as the session progressed, driving the index to the intra-day high of 5,699 points before closing at 161,211 – up 5,433 points. It was not merely a rebound, but a statement rally marked by decisive accumulation and broad-based strength. Index-heavy constituents including Hubco, OGDC, Fauji Fertiliser, Engro Holdings and Meezan Bank led the charge, collectively contributing 2,197 points to the benchmark’s gain and reinforcing the bullish undertone, Topline said.

During the day, shares of 478 companies were traded. Of these, 350 stocks closed higher, 78 fell and 50 remained unchanged.

K-Electric was the volume leader with trading in 115.6 million shares, gaining Rs0.61 to close at Rs8.05. It was followed by Trust Securities & Brokerage (R) with 50.03 million shares, losing Rs0.04 to close at Rs0.18 and Unity Foods with 48.3 million shares, gaining Rs0.55 to close at Rs10.08. Foreign investors sold shares worth Rs1.4 billion, the National Clearing Company reported.



Source link

Continue Reading

Trending